NYSE: ANROAlto Neuroscience Inc Stock Ownership - Who owns Alto Neuroscience?
Insider buying vs selling
Have Alto Neuroscience Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Adam Savitz | CHIEF MEDICAL OFFICER | 2024-07-10 | 2,931 | $13.22 | $38.75kBuy |
| Adam Savitz | CHIEF MEDICAL OFFICER | 2024-07-09 | 1,388 | $13.15 | $18.25kBuy |
| Adam Savitz | CHIEF MEDICAL OFFICER | 2024-07-09 | 10,681 | $12.53 | $133.83kBuy |
ANRO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANRO insiders and whales buy or sell their stock.
ANRO Shareholders
What type of owners hold Alto Neuroscience Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Alpha Wave Global LP | 13.70% | 3,707,757 | $8.38M | Insider |
| Alpha Wave Global LP | 13.70% | 3,707,757 | $8.38M | Institution |
| Point72 Asset Management LP | 6.25% | 1,692,153 | $3.82M | Institution |
| Blackrock Inc | 5.47% | 1,480,014 | $3.34M | Institution |
| Fmr LLC | 4.67% | 1,265,546 | $2.86M | Institution |
| Amit Etkin | 4.58% | 1,240,176 | $2.80M | Insider |
| Vanguard Group Inc | 4.54% | 1,229,667 | $2.78M | Institution |
| Franklin Resources Inc | 4.29% | 1,162,608 | $2.63M | Institution |
| Citadel Advisors LLC | 3.61% | 975,986 | $2.21M | Institution |
| Apeiron Investment Group Ltd | 3.42% | 926,539 | $2.09M | Insider |
ANRO vs Biotech Stocks
Alto Neuroscience Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.